Atea Pharmaceuticals, Inc. (AVIR) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 42 days, typically, give or take 11 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Mon, Nov 9, 2026after close 40 8-K
Q2 FY2026Wed, Aug 12, 2026after close 43 8-K
Q1 FY2026Tue, May 12, 2026after close 42 8-K
Q4 FY2025Thu, Mar 5, 2026after close 64 8-K
Q3 FY2025Wed, Nov 12, 2025after close 43 8-K
Q2 FY2025Thu, Aug 7, 2025after close 38 8-K
Q1 FY2025Mon, May 12, 2025after close 42 8-K
Q4 FY2024Thu, Mar 6, 2025after close 65 8-K

What they guided beta

Q3 FY2026 "Results from C-FORWARD are expected to show the efficacy of BEM/RZR across a broad range of HCV genotypes, to support a New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) targeted for mid-2027." exhibit
Q3 FY2026 "The trial is fully enrolled with more than 880 patients across 17 countries, with topline results expected in early 2027." exhibit
Q3 FY2026 "Based on its current operating plan together with its current cash, cash equivalents and investments, the Company anticipates that these current resources will fund planned operations into mid-2028." exhibit
Q3 FY2026 "In addition, we had lower internal research and development expenses primarily related to lower stock-based compensation expense in the three months ended September 30, 2026." exhibit
Q3 FY2026 "Interest Income and Other, Net: Interest income and other, net, decreased by $1.8 million for the three months ended September 30, 2026 compared to the three months ended September 30, 2025, primarily due to lower investment balances." exhibit
Q2 FY2026 "Atea Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update Phase 3 C-BEYOND Trial Met Primary and Secondary Endpoints, with a Short 8-week Duration for Patients Without Cirrhosis Supporting a Potential Best-in-Class Profile of BEM/RZR for Treatment of HCV C-FORWARD Phase 3 Trial Outside North America on Track with Topline Results Expected Early Q1 2027 AT-587 Phase 1 Clinical Trial Advancing for Treatment of Hepatitis E Virus (HEV) Company Holding Conference Call Today at 4:30 pm ET BOSTON, Mass., August 12, 2026 – Atea Pharmaceuticals, Inc. (Nasdaq: " exhibit
Q2 FY2026 "Topline results are expected in early Q1 2027 and will provide additional efficacy data across a broader range of HCV genotypes more commonly found outside of the US and Canada." exhibit
Q2 FY2026 "Following the recent topline readout for C-BEYOND and pending results from C-FORWARD, Atea anticipates submitting a new drug application (NDA) to the US Food & Drug Administration (FDA) in the second quarter of 2027." exhibit
Q2 FY2026 "The decrease in internal research and development expenses was primarily related to lower stock-based compensation expense in the three months ended June 30, 2026." exhibit
Q2 FY2026 "Interest Income and Other, Net: Interest income and other, net, decreased by $2.2 million for the three months ended June 30, 2026 compared to the three months ended June 30, 2025, primarily due to lower investment balances." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/AVIR
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/AVIR

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

AVIR earnings date badge

HTML

<a href="https://veritasdata.dev/company/AVIR/"><img src="https://veritasdata.dev/embed/AVIR.svg" alt="AVIR earnings date" width="240" height="56"></a>

Markdown

[![AVIR earnings date](https://veritasdata.dev/embed/AVIR.svg)](https://veritasdata.dev/company/AVIR/)

Script

<script async src="https://veritasdata.dev/embed/AVIR.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/AVIR"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.